Literature DB >> 10963362

Different expression of calreticulin and immunoglobulin binding protein in Alzheimer's disease brain.

J Taguchi1, A Fujii, Y Fujino, Y Tsujioka, M Takahashi, Y Tsuboi, I Wada, T Yamada.   

Abstract

Both calreticulin (CRT) and immunoglobulin binding protein (Bip) have a role in the folding and assembly of oligomeric membrane proteins in the endoplasmic reticulum (ER). Recent studies have demonstrated the generation of beta-amyloid protein (Abeta) 1-42, a key peptide for amyloid deposits, in the ER. We, therefore, examined the localization and expression of CRT, Bip and their mRNA by immunohistochemistry, Western blot, in situ hybridization and semiquantitative reverse transcription polymerase chain reaction (RT-PCR) in both neurologically normal and Alzheimer's disease (AD) brains. Two polyclonal anti-CRT antibodies gave similar positive staining of CRT in neurons and glia. In neuronal cells, the cytoplasm, nucleoli and their processes were positive for CRT. In glial cells, perinuclear staining was frequently seen and the processes of some glial cells were also stained. In AD, these antibodies stained clearly damaged neurons but the number and the intensity of positive cells were decreased compared to controls. Processes of microglial cells were markedly positive in the AD white matter. Western blots using an anti-CRT antibody showed significantly lower immunoreactive bands in AD than control brains. By in situ hybridization, the number of neurons which express the CRT mRNA was less in AD than in controls. Using RT-PCR, the relative levels of the CRT mRNA in AD brains were also found to be significantly lower than those in controls. On the other hand, the number of Bip-positive cell, the production of Bip and the expression of mRNA for Bip did not differ between control and AD brains. These results suggest that CRT may be a multifunctional protein in human brain, and that the weak expression of CRT and the positive staining of microglial processes in AD brain may be part of the pathological processes in AD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10963362     DOI: 10.1007/s004019900165

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  13 in total

1.  Reductions of the components of the calreticulin/calnexin quality-control system by proteasome inhibitors and their relevance in a rodent model of Parkinson's disease.

Authors:  Xiu-Li Kuang; Fang Liu; Huifang Chen; Yiping Li; Yimei Liu; Jian Xiao; Ge Shan; Mingjie Li; B Joy Snider; Jia Qu; Steven W Barger; Shengzhou Wu
Journal:  J Neurosci Res       Date:  2014-05-23       Impact factor: 4.164

2.  Time course of SERCA 2b and calreticulin expression in Purkinje neurons of ethanol-fed rats with behavioral correlates.

Authors:  Linda L Cassidy; Frederick F Dlugos; Cynthia A Dlugos
Journal:  Alcohol Alcohol       Date:  2013-07-24       Impact factor: 2.826

3.  The Ca(2+) status of the endoplasmic reticulum is altered by induction of calreticulin expression in transgenic plants.

Authors:  S Persson; S E Wyatt; J Love; W F Thompson; D Robertson; W F Boss
Journal:  Plant Physiol       Date:  2001-07       Impact factor: 8.340

Review 4.  Calreticulin: non-endoplasmic reticulum functions in physiology and disease.

Authors:  Leslie I Gold; Paul Eggleton; Mariya T Sweetwyne; Lauren B Van Duyn; Matthew R Greives; Sara-Megumi Naylor; Marek Michalak; Joanne E Murphy-Ullrich
Journal:  FASEB J       Date:  2009-11-25       Impact factor: 5.191

5.  Hyperoxia augments ER-stress-induced cell death independent of BiP loss.

Authors:  Jennifer S Gewandter; Rhonda J Staversky; Michael A O'Reilly
Journal:  Free Radic Biol Med       Date:  2009-09-26       Impact factor: 7.376

6.  Mitochondrial- and endoplasmic reticulum-associated oxidative stress in Alzheimer's disease: from pathogenesis to biomarkers.

Authors:  E Ferreiro; I Baldeiras; I L Ferreira; R O Costa; A C Rego; C F Pereira; C R Oliveira
Journal:  Int J Cell Biol       Date:  2012-06-04

7.  Targeting Infectious Agents as a Therapeutic Strategy in Alzheimer's Disease.

Authors:  Tamàs Fülöp; Usma Munawara; Anis Larbi; Mathieu Desroches; Serafim Rodrigues; Michele Catanzaro; Andrea Guidolin; Abdelouahed Khalil; François Bernier; Annelise E Barron; Katsuiku Hirokawa; Pascale B Beauregard; David Dumoulin; Jean-Philippe Bellenger; Jacek M Witkowski; Eric Frost
Journal:  CNS Drugs       Date:  2020-07       Impact factor: 6.497

8.  The ATF6β-calreticulin axis promotes neuronal survival under endoplasmic reticulum stress and excitotoxicity.

Authors:  Dinh Thi Nguyen; Thuong Manh Le; Tsuyoshi Hattori; Mika Takarada-Iemata; Hiroshi Ishii; Jureepon Roboon; Takashi Tamatani; Takayuki Kannon; Kazuyoshi Hosomichi; Atsushi Tajima; Shusuke Taniuchi; Masato Miyake; Seiichi Oyadomari; Takashi Tanaka; Nobuo Kato; Shunsuke Saito; Kazutoshi Mori; Osamu Hori
Journal:  Sci Rep       Date:  2021-06-22       Impact factor: 4.379

9.  Generation of amyloid-β is reduced by the interaction of calreticulin with amyloid precursor protein, presenilin and nicastrin.

Authors:  Nina Stemmer; Elena Strekalova; Nevena Djogo; Frank Plöger; Gabriele Loers; David Lutz; Friedrich Buck; Marek Michalak; Melitta Schachner; Ralf Kleene
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

10.  Biana: a software framework for compiling biological interactions and analyzing networks.

Authors:  Javier Garcia-Garcia; Emre Guney; Ramon Aragues; Joan Planas-Iglesias; Baldo Oliva
Journal:  BMC Bioinformatics       Date:  2010-01-27       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.